Cargando…
Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice
There are not many real-world studies evaluating daily insulin doses requirements (DIDR) in patients with type 1 diabetes (T1D) using second-generation basal insulin analogs, and such comparison is necessary. The aim of this study was to compare DIDR in individuals with T1D using glargine 300 UI/mL...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223633/ https://www.ncbi.nlm.nih.gov/pubmed/33771843 http://dx.doi.org/10.1136/jim-2020-001633 |